Primary record
6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; AM 833; Flerofloxacin; Fleroxacin; Megalocin; Megalone; Quinodis; Ro 23-6240; Ro 23-6240/000
- 库存
- 822 克
- 纯度
- 99.2 %
- CAS
- 79660-72-3
化合物标识与属性
- CAS
- 79660-72-3
- PubChem CID
- 3357
- SMILES
- CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F
- Canonical SMILES
- CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1
名称与同义词
- fleroxacin
- Megalone
- Megalocin
- Fleroxicin
- Quinodis
- Fleroxacino
- Fleroxacine
- Fleroxacinum
- 79660-72-3
- Megalosin
- flerofloxacin
- Barutoneru
- Fulemegacin
- Fulmicocin
- FLRX
- Megaxacin
- Fleroxacine [French]
- Fleroxacinum [Latin]
- Fleroxacino [Spanish]
- Megalocin (TN)
- Megalone (TN)
- Fleroxacin (Quinodis)
- FLRX[Fleroxacin]
- Quinodis (TN)
- AM-833
- 5-Mercaptomethyluracil
- AM 833
- FLEROXACIN [MI]
- DTXSID1046714
- CHEBI:31810
- FLEROXACIN [INN]
- FLEROXACIN [JAN]
- RefChem:388981
- C17H18F3N3O3
- CCRIS 3972
- FLEROXACIN [USAN]
- N804LDH51K
- Ro 23-6240
- UNII-N804LDH51K
- Ro-236240
- MFCD00864880
- D06GAM
- Epitope ID:540292
- Fleroxacin (JAN/USAN/INN)
- AC1L1FR2
- AC1Q3ZU5
- FLEROXACIN [MART.]
- Ro 23-6240/000
- XBJBPGROQZJDOJ-UHFFFAOYSA-N
- CHEMBL6273
- FLEROXACIN [WHO-DD]
- Fleroxacin [USAN:BAN:INN:JAN]
- SCHEMBL48145
- DTXCID9026714
- KSC492E5H
- MLS000759401
- MLS006010715
- 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
- AC1Q4N64
- AM833
- Fleroxacin [USAN:INN:BAN:JAN]
- orb1309083
- orb3025543
- Fleroxacin, 98% - 1G 1g
- SCHEMBL29377022
- CTK3J2253
- GTPL12476
- KS-00000XUW
- Ro-23-6240/000
- BRN 4300996
- CID3357
- J01MA08
- MSK5719
- Ro-236240000
- HMS2090I08
- HMS3715B11
- MSK5719-100DM
- BCP28939
- CID:3357
- HY-B0414
- RKL10075
- Ro 236240
- ZINC3786299
- MSK5719-1000DM
- Tox21_112553
- ANW-42889
- AR-1H0470
- BDBM50247892
- MSK5719-100D
- MSK5719-100M
- NCGC00167558-01
- Ro 23 6240
- s2469
- ZINC03786299
- AKOS015907011
- MSK5719-1000D
- Tox21_112553_1
- AF23303
- C17-H18-F3-N3-O3
- CCG-221125
- CS-2518
- DB04576
- KS-5124
- RTR-025289
- VQ10280
- RO 23-6240;AM-833
- 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
- F0646
- Fleroxacin Solution in DMSO, 100ug/mL
- NCGC00167558-02
- Ro-23-6240
- AM-833;AM833;AM 833
- AN-36581
- CPD000466302
- J23.768J
- SAM001246535
- SC-58138
- SMR000466302
- SY057457
- Fleroxacin Solution in DMSO, 1000ug/mL
- SID:134222641
- AB1010903
- CAS-79660-72-3
- Fleroxacin Solution in Methanol, 100ug/mL
- LS-141577
- PF-562271
- TR-025289
- B1756
- FT-0630874
- NS00005485
- C13179
- D01716
- Fleroxacin, VETRANAL(TM), analytical standard
- J10168
- 3-Quinolinecarboxylic acid, 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-
- AB00640001-02
- AB00640001-03
- AB00640001_04
- Fleroxacin Solution in DMSO/Methanol, 100ug/mL
- 660F723
- A839732
- D016576
- F858783
- Fleroxacin Solution in DMSO/Methanol, 1000ug/mL
- SR-01000759379
- Q3746573
- SR-01000759379-2
- SR-01000759379-3
- 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
- BRD-K61717546-001-04-3
- BRD-K61717546-001-05-0
- 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid
- Fleroxacin, Quinodis, Megalocin, AM 833, Ro 236240
- 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
- 3-Quinolinecarboxylic acid, 1,4-dihydro-6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-
- 1,4-Dihydro-4-oxo-1-(2-fluoroethyl)-6,8-difluoro-7-(4-methylpiperazine-1-yl)quinoline-3-carboxylic acid
- 1-(2-Fluoroethyl)-6,8-difluoro-1,4-dihydro-4-oxo-7-(4-methylpiperazino)-3-quinolinecarboxylic acid
- 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(4-methyl-1-piperazinyl)quinoline-3-carboxylic acid
- 6,8-Difluoro-1-(2-Fluoroethyl)-1,4-Dihydro-7-(4-Methyl-1-Piperazinyl)-4-Oxo-3-Quinolinecarboxylic Ac
- 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid-
- 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; AM 833; Flerofloxacin; Fleroxacin; Megalocin; Megalone; Quinodis; Ro 23-6240; Ro 23-6240/000
- 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; Megalone
- 6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
- 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid
- 6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 6,8-Difluoro-1-(2-fluoroethyl)1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
- 677-525-2
- 717907-75-0
- 79660-53-0
- 838-67-5
- FLE
- Methanesulfonamide, N-[3-[[[2-[(2,3-dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methyl-